BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21553087)

  • 1. The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
    Sørensen M; Frisch K; Bender D; Keiding S
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1723-31. PubMed ID: 21553087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
    Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
    Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Bak-Fredslund KP; Keiding S; Villadsen GE; Kramer S; Schlander S; Sørensen M
    Liver Int; 2020 Feb; 40(2):447-455. PubMed ID: 31705784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
    J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma.
    Bieze M; Klümpen HJ; Verheij J; Beuers U; Phoa SS; van Gulik TM; Bennink RJ
    Hepatology; 2014 Mar; 59(3):996-1006. PubMed ID: 24123111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.
    Horsager J; Bak-Fredslund K; Larsen LP; Villadsen GE; Bogsrud TV; Sørensen M
    EJNMMI Res; 2016 Dec; 6(1):56. PubMed ID: 27341819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Villadsen GE; Keiding S
    J Hepatol; 2013 Jun; 58(6):1119-24. PubMed ID: 23339954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
    Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
    J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[
    Fode MM; Bak-Fredslund K; Petersen JB; Worm E; Sørensen M; Høyer M
    Acta Oncol; 2017 Nov; 56(11):1614-1620. PubMed ID: 28849688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
    Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
    J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model.
    Frisch K; Bender D; Hansen SB; Keiding S; Sørensen M
    Nucl Med Biol; 2011 May; 38(4):477-83. PubMed ID: 21531284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
    Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
    Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [
    Sørensen M; Fode MM; Petersen JB; Holt MI; Høyer M
    Radiat Oncol; 2021 Oct; 16(1):192. PubMed ID: 34598730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
    Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
    Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.